Synopsis of recent research by authors named "Xugang Ji"
- Xugang Ji's research primarily focuses on the development of innovative drug delivery systems, particularly utilizing targeting nanoparticles to enhance the therapeutic efficacy and bioavailability of anticancer agents, such as curcumin and doxorubicin, in tackling multidrug-resistant breast cancer.
- His studies highlight the incorporation of folate receptors and specific peptides to improve cellular targeting and penetration, addressing challenges related to poor drug uptake and resistance mechanisms inherent in cancer therapies.
- Recent findings include the successful synthesis of various nanoparticle formulations, such as folate-modified β-cyclodextrin nanoparticles and enzyme-targeted hybrid nanoparticles, which demonstrate sustained drug release profiles and improved antitumor activities in experimental models.
